世界のオベチコール酸薬市場:成長動向・競争分析2020-2026

【英語タイトル】Global Obeticholic Acid Drug Industry Research Report, Growth Trends and Competitive Analysis 2020-2026

QYResearchが出版した調査資料(QYR20AP01627)・商品コード:QYR20AP01627
・発行会社(調査会社):QYResearch
・発行日:2020年3月23日(※2024年版があります。お問い合わせください)
・ページ数:111
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,900 ⇒換算¥725,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD7,350 ⇒換算¥1,087,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD9,800 ⇒換算¥1,450,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
当リサーチレポートでは、オベチコール酸薬の世界市場規模が2019年xx百万ドルから2026年xx百万ドルまで年平均xx%成長すると予測しています。当レポートは、オベチコール酸薬のグローバル市場動向、メーカー別競争状況、種類別市場規模(5mg、10mg)、用途別市場規模(原発性胆汁性肝硬変、非アルコール性脂肪性肝疾患、その他)、北米市場、アジア市場、中南米市場、中東・アフリカ市場分析、関連企業情報、サプライチェーン、販売チャネル分析、地域別市場規模予測データなどを掲載しています。

・レポート概要
・グローバル市場動向
・メーカー別競争状況
・オベチコール酸薬の種類別市場2015-2026:5mg、10mg
・オベチコール酸薬の用途別市場2015-2026:原発性胆汁性肝硬変、非アルコール性脂肪性肝疾患、その他
・オベチコール酸薬の北米市場分析
・オベチコール酸薬のアジア市場分析
・オベチコール酸薬の中南米市場分析
・オベチコール酸薬の中東・アフリカ市場分析
・関連企業情報:Intercept Pharmaceuticals、Dainippon Sumitomo Pharma
・サプライチェーン及び販売チャネル分析
・地域別市場規模予測2021-2026:北米、ヨーロッパ、アジア、中南米、中東・アフリカ
・結論
【レポートの概要】

Obeticholic acid is a semi-synthetic bile acid analogue which has the chemical structure 6α-ethyl-chenodeoxycholic acid.In 2019, the global Obeticholic Acid Drug market size was US$ xx million and is forecast to US$ xx million in 2026, growing at a CAGR of xx% from 2020. In this study, 2019 has been considered as the base year and 2020 to 2026 as the forecast period to estimate the market size for Obeticholic Acid Drug.
The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global Obeticholic Acid Drug market. The analysts authoring the report have closely studied key strategies adopted by top players of the global Obeticholic Acid Drug market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global Obeticholic Acid Drug market. Readers of the report can become informed about current and future trends of the global Obeticholic Acid Drug market and how they will impact market growth during the forecast period.
Geographic Segmentation
The report offers exhaustive assessment of different region-wise and country-wise Obeticholic Acid Drug markets such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E etc.
For the period 2015-2026, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Obeticholic Acid Drug market. For the period 2015-2020, it provides sales (consumption) analysis and forecast of different regional markets by Application as well as by Type in terms of volume.
Market Segmentation by Type and by Application
The report includes a detailed analysis of leading and by Type and by Application segments of the global Obeticholic Acid Drug market. All of the segments covered in the report are broadly analyzed based on some deciding factors. The segmental analysis section of the report offers revenue, sales analysis and forecast of the global Obeticholic Acid Drug market by Type and by Application segment for the period 2015-2026.

Market Segment by Type, the Obeticholic Acid Drug market is segmented into
5mg
10mg

Market Segment by Application, the Obeticholic Acid Drug market is segmented into
Primary Biliary Cirrhosis
Nonalcoholic Fatty Liver Disease
Other

This report includes the following manufacturers; we can also add the other companies as you want.
Intercept Pharmaceuticals
Dainippon Sumitomo Pharma

The study objectives are:
To analyze and research the global Obeticholic Acid Drug status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Obeticholic Acid Drug manufacturers, capacity, production, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Obeticholic Acid Drug are as follows:
History Year: 2015-2020
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Top Obeticholic Acid Drug Manufacturers Covered: Ranking by Revenue
1.3 Market Segment by Type
1.3.1 Global Obeticholic Acid Drug Market Size by Type: 2015 VS 2020 VS 2026 (US$ Million)
1.3.2 5mg
1.3.3 10mg
1.4 Market Segment by Application
1.4.1 Global Obeticholic Acid Drug Consumption by Application: 2015 VS 2020 VS 2026
1.4.2 Primary Biliary Cirrhosis
1.4.3 Nonalcoholic Fatty Liver Disease
1.4.4 Other
1.5 Study Objectives
1.6 Years Considered
2 Global Market Perspective
2.1 Global Obeticholic Acid Drug Revenue (2015-2026)
2.1.1 Global Obeticholic Acid Drug Revenue (2015-2026)
2.1.2 Global Obeticholic Acid Drug Sales (2015-2026)
2.2 Obeticholic Acid Drug Market Size across Key Geographies Worldwide: 2015 VS 2020 VS 2026
2.2.1 Global Obeticholic Acid Drug Sales by Regions (2015-2020)
2.2.2 Global Obeticholic Acid Drug Revenue by Regions (2015-2020)
2.3 Global Top Obeticholic Acid Drug Regions (Countries) Ranking by Market Size
2.4 Obeticholic Acid Drug Industry Trends
2.4.1 Obeticholic Acid Drug Market Top Trends
2.4.2 Market Drivers
2.4.3 Obeticholic Acid Drug Market Challenges
2.4.4 Porter’s Five Forces Analysis
2.4.5 Primary Interviews with Key Obeticholic Acid Drug Players: Views for Future

3 Competitive Landscape by Manufacturers
3.1 Global Top Obeticholic Acid Drug Manufacturers by Sales (2015-2020)
3.1.1 Global Obeticholic Acid Drug Sales by Manufacturers (2015-2020)
3.1.2 Global Obeticholic Acid Drug Sales Market Share by Manufacturers (2015-2020)
3.1.3 Global 5 and 10 Largest Manufacturers by Obeticholic Acid Drug Sales in 2019
3.2 Global Top Manufacturers Obeticholic Acid Drug by Revenue
3.2.1 Global Obeticholic Acid Drug Revenue by Manufacturers (2015-2020)
3.2.2 Global Obeticholic Acid Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Obeticholic Acid Drug Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Obeticholic Acid Drug as of 2019)
3.4 Global Obeticholic Acid Drug Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Obeticholic Acid Drug Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Obeticholic Acid Drug Market
3.7 Key Manufacturers Obeticholic Acid Drug Product Offered
3.8 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Obeticholic Acid Drug Historic Market Review by Type (2015-2020)
4.1.2 Global Obeticholic Acid Drug Sales Market Share by Type (2015-2020)
4.1.3 Global Obeticholic Acid Drug Revenue Market Share by Type (2015-2020)
4.1.4 Obeticholic Acid Drug Price by Type (2015-2020)
4.1 Global Obeticholic Acid Drug Market Estimates and Forecasts by Type (2021-2026)
4.2.2 Global Obeticholic Acid Drug Sales Forecast by Type (2021-2026)
4.2.3 Global Obeticholic Acid Drug Revenue Forecast by Type (2021-2026)
4.2.4 Obeticholic Acid Drug Price Forecast by Type (2021-2026)

5 Global Obeticholic Acid Drug Market Size by Application
5.1 Global Obeticholic Acid Drug Historic Market Review by Application (2015-2020)
5.1.2 Global Obeticholic Acid Drug Sales Market Share by Application (2015-2020)
5.1.3 Global Obeticholic Acid Drug Revenue Market Share by Application (2015-2020)
5.1.4 Obeticholic Acid Drug Price by Application (2015-2020)
5.2 Global Obeticholic Acid Drug Market Estimates and Forecasts by Application (2021-2026)
5.2.2 Global Obeticholic Acid Drug Sales Forecast by Application (2021-2026)
5.2.3 Global Obeticholic Acid Drug Revenue Forecast by Application (2021-2026)
5.2.4 Obeticholic Acid Drug Price Forecast by Application (2021-2026)

6 North America
6.1 North America Obeticholic Acid Drug Breakdown Data by Company
6.2 North America Obeticholic Acid Drug Breakdown Data by Type
6.3 North America Obeticholic Acid Drug Breakdown Data by Application
6.4 North America Obeticholic Acid Drug Breakdown Data by Countries
6.4.1 North America Obeticholic Acid Drug Sales by Countries
6.4.2 North America Obeticholic Acid Drug Revenue by Countries
6.4.3 U.S.
6.4.4 Canada

7 Europe
7.1 Europe Obeticholic Acid Drug Breakdown Data by Company
7.2 Europe Obeticholic Acid Drug Breakdown Data by Type
7.3 Europe Obeticholic Acid Drug Breakdown Data by Application
7.4 Europe Obeticholic Acid Drug Breakdown Data by Countries
7.4.1 Europe Obeticholic Acid Drug Sales by Countries
7.4.2 Europe Obeticholic Acid Drug Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific Obeticholic Acid Drug Breakdown Data by Company
8.2 Asia Pacific Obeticholic Acid Drug Breakdown Data by Type
8.3 Asia Pacific Obeticholic Acid Drug Breakdown Data by Application
8.4 Asia Pacific Obeticholic Acid Drug Breakdown Data by Regions
8.4.1 Asia Pacific Obeticholic Acid Drug Sales by Regions
8.4.2 Asia Pacific Obeticholic Acid Drug Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam

9 Latin America
9.1 Latin America Obeticholic Acid Drug Breakdown Data by Company
9.2 Latin America Obeticholic Acid Drug Breakdown Data by Type
9.3 Latin America Obeticholic Acid Drug Breakdown Data by Application
9.4 Latin America Obeticholic Acid Drug Breakdown Data by Countries
9.4.1 Latin America Obeticholic Acid Drug Sales by Countries
9.4.2 Latin America Obeticholic Acid Drug Revenue by Countries
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Obeticholic Acid Drug Breakdown Data by Type
10.2 Middle East and Africa Obeticholic Acid Drug Breakdown Data by Application
10.3 Middle East and Africa Obeticholic Acid Drug Breakdown Data by Countries
10.3.1 Middle East and Africa Obeticholic Acid Drug Sales by Countries
10.3.2 Middle East and Africa Obeticholic Acid Drug Revenue by Countries
10.3.3 Turkey
10.3.4 Saudi Arabia
10.3.5 U.A.E

11 Company Profiles
11.1 Intercept Pharmaceuticals
11.1.1 Intercept Pharmaceuticals Corporation Information
11.1.2 Intercept Pharmaceuticals Business Overview and Total Revenue (2019 VS 2018)
11.1.3 Intercept Pharmaceuticals Obeticholic Acid Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.1.4 Intercept Pharmaceuticals Obeticholic Acid Drug Products and Services
11.1.5 Intercept Pharmaceuticals SWOT Analysis
11.1.6 Intercept Pharmaceuticals Recent Developments
11.2 Dainippon Sumitomo Pharma
11.2.1 Dainippon Sumitomo Pharma Corporation Information
11.2.2 Dainippon Sumitomo Pharma Business Overview and Total Revenue (2019 VS 2018)
11.2.3 Dainippon Sumitomo Pharma Obeticholic Acid Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.2.4 Dainippon Sumitomo Pharma Obeticholic Acid Drug Products and Services
11.2.5 Dainippon Sumitomo Pharma SWOT Analysis
11.2.6 Dainippon Sumitomo Pharma Recent Developments

12 Supply Chain and Sales Channels Analysis
12.1 Supply Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Obeticholic Acid Drug Sales Channels
12.2.2 Obeticholic Acid Drug Distributors
12.3 Obeticholic Acid Drug Customers

13 Estimates and Projections by Regions (2021-2026)
13.1 Global Obeticholic Acid Drug Sales Forecast (2021-2026)
13.1.1 Global Obeticholic Acid Drug Sales Forecast by Regions (2021-2026)
13.1.2 Global Obeticholic Acid Drug Revenue Forecast by Regions (2021-2026)
13.2 North America Market Size Forecast (2021-2026)
13.2.1 North America Obeticholic Acid Drug Sales Forecast (2021-2026)
13.2.2 North America Obeticholic Acid Drug Revenue Forecast (2021-2026)
13.2.3 North America Obeticholic Acid Drug Size Forecast by County (2021-2026)
13.3 Europe Market Size Forecast (2021-2026)
13.3.1 Europe Obeticholic Acid Drug Sales Forecast (2021-2026)
13.3.2 Europe Obeticholic Acid Drug Revenue Forecast (2021-2026)
13.3.3 Europe Obeticholic Acid Drug Size Forecast by County (2021-2026)
13.4 Asia Pacific Market Size Forecast (2021-2026)
13.4.1 Asia Pacific Obeticholic Acid Drug Sales Forecast (2021-2026)
13.4.2 Asia Pacific Obeticholic Acid Drug Revenue Forecast (2021-2026)
13.4.3 Asia Pacific Obeticholic Acid Drug Size Forecast by Region (2021-2026)
13.5 Latin America Market Size Forecast (2021-2026)
13.5.1 Latin America Obeticholic Acid Drug Sales Forecast (2021-2026)
13.5.2 Latin America Obeticholic Acid Drug Revenue Forecast (2021-2026)
13.5.3 Latin America Obeticholic Acid Drug Size Forecast by County (2021-2026)
13.6 Middle East and Africa Market Forecast
13.6.1 Middle East and Africa Obeticholic Acid Drug Sales Forecast (2021-2026)
13.6.2 Middle East and Africa Obeticholic Acid Drug Revenue Forecast (2021-2026)
13.6.3 Middle East and Africa Obeticholic Acid Drug Size Forecast by County (2021-2026)

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Obeticholic Acid Drug Key Market Segments
Table 2. Ranking of Global Top Obeticholic Acid Drug Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Obeticholic Acid Drug Market Size Growth Rate by Type 2021-2026 (K Units) & (Million US$)
Table 4. Major Manufacturers of 5mg
Table 5. Major Manufacturers of 10mg
Table 6. Global Obeticholic Acid Drug Market Share by Application 2019-2025 (K Units)
Table 7. Global Obeticholic Acid Drug Market Size by Regions 2015-2020 (K Units) & (Million US$)
Table 8. Global Obeticholic Acid Drug Sales by Regions 2015-2020 (K Units)
Table 9. Global Obeticholic Acid Drug Sales Market Share by Regions 2015-2020
Table 10. Global Obeticholic Acid Drug Revenue by Regions 2015-2020 (Million US$)
Table 11. Global Obeticholic Acid Drug Revenue Market Share by Regions 2015-2020
Table 12. Top Obeticholic Acid Drug Regions (Countries) Ranking by Market Size (US$ Million) in 2019
Table 13. Market Top Trends
Table 14. Obeticholic Acid Drug Key Drivers: Impact Analysis (2021-2026)
Table 15. Obeticholic Acid Drug Key Challenges
Table 16. Main Points Interviewed from Key Obeticholic Acid Drug Players: Views for Future
Table 17. Global Obeticholic Acid Drug Sales by Manufacturers (2015-2020) (K Units)
Table 18. Global Obeticholic Acid Drug Sales Share by Manufacturers (2015-2020)
Table 19. Obeticholic Acid Drug Revenue by Manufacturers (2015-2020) (Million US$)
Table 20. Obeticholic Acid Drug Revenue Share by Manufacturers (2015-2020)
Table 21. Global Obeticholic Acid Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Obeticholic Acid Drug as of 2019)
Table 23. Key Manufacturers Obeticholic Acid Drug Average Selling Price (ASP) (2015-2020) (USD/Unit)
Table 24. Key Manufacturers Obeticholic Acid Drug Plants/Factories Distribution
Table 25. Key Manufacturers Obeticholic Acid Drug Area Served
Table 26. Date of Key Manufacturers Enter into Obeticholic Acid Drug Market
Table 27. Key Manufacturers Obeticholic Acid Drug Product Type
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global 5mg Sales and Revenue (2015-2020) (K Units) & (Million US$)
Table 30. Global 10mg Sales and Revenue (2015-2020) (K Units) & (Million US$)
Table 31. Global Obeticholic Acid Drug Sales (K Units) by Type (2015-2020)
Table 32. Global Obeticholic Acid Drug Sales Share by Type (2015-2020)
Table 33. Global Obeticholic Acid Drug Revenue (US$ Million) Market Share by Type (2015-2020)
Table 34. Global Obeticholic Acid Drug Price (K Units) by Type (2015-2020)
Table 35. Global Obeticholic Acid Drug Sales (K Units) by Type (2021-2026)
Table 36. Global Obeticholic Acid Drug Sales Share by Type (2021-2026)
Table 37. Global Obeticholic Acid Drug Revenue (US$ Million) Market Share by Type (2021-2026)
Table 38. Global Obeticholic Acid Drug Revenue Share by Type (2021-2026)
Table 39. Global Obeticholic Acid Drug Price (K Units) by Type (2021-2026)
Table 40. Global Obeticholic Acid Drug Sales (K Units) by Application (2015-2020)
Table 41. Global Obeticholic Acid Drug Sales Share by Application (2015-2020)
Table 42. Global Obeticholic Acid Drug Revenue (US$ Million) Market Share by Application (2015-2020)
Table 43. Global Obeticholic Acid Drug Price by Application 2015-2020 (USD/Unit)
Table 44. Global Obeticholic Acid Drug Sales by Application (2015-2020) (K Units)
Table 45. Global Obeticholic Acid Drug Sales Share by Application (2015-2020)
Table 46. Global Obeticholic Acid Drug Revenue (US$ Million) Market Share by Application (2021-2026)
Table 47. Global Obeticholic Acid Drug Revenue Share by Application (2021-2026)
Table 48. Global Obeticholic Acid Drug Price (K Units) by Application (2021-2026)
Table 49. North America Obeticholic Acid Drug Sales by Company (2015-2020) (K Units)
Table 50. North America Obeticholic Acid Drug Sales Market Share by Company (2015-2020)
Table 51. North America Obeticholic Acid Drug Sales by Type (2015-2020) (K Units)
Table 52. North America Obeticholic Acid Drug Sales Market Share by Type (2015-2020)
Table 53. North America Obeticholic Acid Drug Sales by Application (2015-2020) (K Units)
Table 54. North America Obeticholic Acid Drug Sales Market Share by Application (2015-2020)
Table 55. North America Obeticholic Acid Drug Sales by Countries (2015-2020) (K Units)
Table 56. North America Obeticholic Acid Drug Sales Market Share by Countries (2015-2020)
Table 57. North America Obeticholic Acid Drug Revenue by Countries (2015-2020) (Million US$)
Table 58. North America Obeticholic Acid Drug Revenue Market Share by Countries (2015-2020)
Table 59. Europe Obeticholic Acid Drug Sales by Company (2015-2020) (K Units)
Table 60. Europe Obeticholic Acid Drug Sales Market Share by Company (2015-2020)
Table 61. Europe Obeticholic Acid Drug Sales by Type (2015-2020) (K Units)
Table 62. Europe Obeticholic Acid Drug Sales Market Share by Type (2015-2020)
Table 63. Europe Obeticholic Acid Drug Sales by Application (2015-2020) (K Units)
Table 64. Europe Obeticholic Acid Drug Sales Market Share by Application (2015-2020)
Table 65. Europe Obeticholic Acid Drug Sales by Countries (2015-2020) (K Units)
Table 66. Europe Obeticholic Acid Drug Sales Market Share by Countries (2015-2020)
Table 67. Europe Obeticholic Acid Drug Revenue by Countries (2015-2020) (Million US$)
Table 68. Europe Obeticholic Acid Drug Revenue Market Share by Countries (2015-2020)
Table 69. Asia Pacific Obeticholic Acid Drug Sales by Regions (2015-2020) (K Units)
Table 70. Asia Pacific Obeticholic Acid Drug Sales Market Share by Regions (2015-2020)
Table 71. Asia Pacific Obeticholic Acid Drug Sales by Type (2015-2020) (K Units)
Table 72. Asia Pacific Obeticholic Acid Drug Sales Market Share by Type (2015-2020)
Table 73. Asia Pacific Obeticholic Acid Drug Sales by Application (2015-2020) (K Units)
Table 74. Asia Pacific Obeticholic Acid Drug Sales Market Share by Application (2015-2020)
Table 75. Asia Pacific Obeticholic Acid Drug Sales by Countries (2015-2020) (K Units)
Table 76. Asia Pacific Obeticholic Acid Drug Sales Market Share by Regions (2015-2020)
Table 77. Asia Pacific Obeticholic Acid Drug Revenue by Regions (2015-2020) (Million US$)
Table 78. Asia Pacific Obeticholic Acid Drug Revenue Market Share by Regions (2015-2020)
Table 79. Latin America Obeticholic Acid Drug Sales by Company (2015-2020) (K Units)
Table 80. Latin America Obeticholic Acid Drug Sales Market Share by Company (2015-2020)
Table 81. Latin America Obeticholic Acid Drug Sales by Type (2015-2020) (K Units)
Table 82. Latin America Obeticholic Acid Drug Sales Market Share by Type (2015-2020)
Table 83. Latin America Obeticholic Acid Drug Sales by Application (2015-2020) (K Units)
Table 84. Latin America Obeticholic Acid Drug Sales Market Share by Application (2015-2020)
Table 85. Latin America Obeticholic Acid Drug Sales by Countries (2015-2020) (K Units)
Table 86. Latin America Obeticholic Acid Drug Sales Market Share by Countries (2015-2020)
Table 87. Latin America Obeticholic Acid Drug Revenue by Countries (2015-2020) (Million US$)
Table 88. Latin America Obeticholic Acid Drug Revenue Market Share by Countries (2015-2020)
Table 89. Middle East and Africa Obeticholic Acid Drug Sales by Type (2015-2020) (K Units)
Table 90. Middle East and Africa Obeticholic Acid Drug Sales Market Share by Type (2015-2020)
Table 91. Middle East and Africa Obeticholic Acid Drug Sales by Application (2015-2020) (K Units)
Table 92. Middle East and Africa Obeticholic Acid Drug Sales Market Share by Application (2015-2020)
Table 93. Middle East and Africa Obeticholic Acid Drug Sales by Countries (2015-2020) (K Units)
Table 94. Middle East and Africa Obeticholic Acid Drug Sales Market Share by Countries (2015-2020)
Table 95. Middle East and Africa Obeticholic Acid Drug Revenue by Countries (2015-2020) (Million US$)
Table 96. Middle East and Africa Obeticholic Acid Drug Revenue Market Share by Countries (2015-2020)
Table 97. Intercept Pharmaceuticals Company Details
Table 98. Intercept Pharmaceuticals Description and Business Overview
Table 99. Intercept Pharmaceuticals Obeticholic Acid Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 100. Intercept Pharmaceuticals Obeticholic Acid Drug Sales Growth Rate (2015-2020)
Table 101. Intercept Pharmaceuticals Obeticholic Acid Drug Sales Market Share in Global Market
Table 102. Intercept Pharmaceuticals Recent Development
Table 103. Dainippon Sumitomo Pharma Company Details
Table 104. Dainippon Sumitomo Pharma Description and Business Overview
Table 105. Dainippon Sumitomo Pharma Obeticholic Acid Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 106. Dainippon Sumitomo Pharma Obeticholic Acid Drug Sales Growth Rate (2015-2020)
Table 107. Dainippon Sumitomo Pharma Obeticholic Acid Drug Sales Market Share in Global Market
Table 108. Dainippon Sumitomo Pharma Recent Development
Table 109. Obeticholic Acid Drug Distributors List
Table 110. Obeticholic Acid Drug Customers List
Table 111. Global Obeticholic Acid Drug Sales Forecast 2021-2026 (K Units) & (Million US$)
Table 112. Global Obeticholic Acid Drug Sales Forecast by Type 2021-2026 (K Units)
Table 113. Global Obeticholic Acid Drug Sales Forecast by Application 2021-2026 (K Units)
Table 114. Global Obeticholic Acid Drug Sales Forecast by Regions 2021-2026 (K Units)
Table 115. Global Obeticholic Acid Drug Revenue Forecast by Regions 2021-2026 (Million US$)
Table 116. North America Obeticholic Acid Drug Sales Forecast by Countries 2021-2026 (K Units)
Table 117. North America Obeticholic Acid Drug Revenue Forecast by Countries 2021-2026
Table 118. Europe Obeticholic Acid Drug Sales Forecast by Countries 2021-2026 (K Units)
Table 119. Europe Obeticholic Acid Drug Revenue Market Share Forecast by Countries 2021-2026
Table 120. Asia Pacific Obeticholic Acid Drug Sales Forecast by Regions 2021-2026 (K Units)
Table 121. Asia Pacific Obeticholic Acid Drug Revenue Forecast by Regions 2021-2026 (Million US$)
Table 122. Latin America Obeticholic Acid Drug Sales Forecast by Countries 2021-2026 (K Units)
Table 123. Latin America Obeticholic Acid Drug Revenue Forecast by Countries 2021-2026 (Million US$)
Table 124. Middle East and Africa Obeticholic Acid Drug Sales Forecast by Regions 2021-2026 (K Units)
Table 125. Middle East and Africa Obeticholic Acid Drug Revenue Forecast by Regions 2021-2026 (Million US$)
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Obeticholic Acid Drug Product Picture
Figure 2. Global Obeticholic Acid Drug Sales Market Shar by Type 2015-2026
Figure 3. 5mg Figures
Figure 4. 10mg Figures
Figure 5. Global Obeticholic Acid Drug Sales Market Share by Application in 2019 & 2026
Figure 6. Primary Biliary Cirrhosis Use Case
Figure 7. Nonalcoholic Fatty Liver Disease Use Case
Figure 8. Other Use Case
Figure 9. Obeticholic Acid Drug Report Years Considered
Figure 10. Global Obeticholic Acid Drug Market Size 2015-2026 (Million US$)
Figure 11. Global Obeticholic Acid Drug Sales 2015-2020 (K Units)
Figure 12. Global Obeticholic Acid Drug Market Size Market Share by Regions 2015-2020
Figure 13. Global Obeticholic Acid Drug Sales Market Share by Regions in 2019
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Obeticholic Acid Drug Sales Share by Manufacturers in 2019
Figure 16. The 5 and 10 Largest Manufacturers in the World: Market Share by Obeticholic Acid Drug Sales in 2019
Figure 17. Obeticholic Acid Drug Value Share by Manufacturers in 2019
Figure 18. Obeticholic Acid Drug Revenue Share by Manufacturers In 2019
Figure 19. Obeticholic Acid Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Obeticholic Acid Drug Revenue Share by Type (2015-2020)
Figure 21. Global Obeticholic Acid Drug Revenue Growth Rate by Type in 2015 & 2019
Figure 22. Global Obeticholic Acid Drug Market Share by Price Range (2015-2020)
Figure 23. Global Obeticholic Acid Drug Revenue Share by Application (2015-2020)
Figure 24. Global Obeticholic Acid Drug Revenue Growth Rate by Application in 2015 & 2019
Figure 25. North America Obeticholic Acid Drug Revenue Growth Rate 2015-2020 (Million US$)
Figure 26. U.S. Obeticholic Acid Drug Sales Growth Rate (2015-2020) (K Units)
Figure 27. Canada Obeticholic Acid Drug Sales Growth Rate (2015-2020) (K Units)
Figure 28. Europe Obeticholic Acid Drug Revenue Growth Rate 2015-2020 (Million US$)
Figure 29. Germany Obeticholic Acid Drug Sales Growth Rate (2015-2020) (K Units)
Figure 30. France Obeticholic Acid Drug Sales Growth Rate (2015-2020) (K Units)
Figure 31. U.K. Obeticholic Acid Drug Sales Growth Rate (2015-2020) (K Units)
Figure 32. Italy Obeticholic Acid Drug Sales Growth Rate (2015-2020) (K Units)
Figure 33. Russia Obeticholic Acid Drug Sales Growth Rate (2015-2020) (K Units)
Figure 34. Asia Pacific Obeticholic Acid Drug Revenue Growth Rate 2015-2020 (Million US$)
Figure 35. China Obeticholic Acid Drug Sales Growth Rate (2015-2020) (K Units)
Figure 36. Japan Obeticholic Acid Drug Sales Growth Rate (2015-2020) (K Units)
Figure 37. South Korea Obeticholic Acid Drug Sales Growth Rate (2015-2020) (K Units)
Figure 38. India Obeticholic Acid Drug Sales Growth Rate (2015-2020) (K Units)
Figure 39. Australia Obeticholic Acid Drug Sales Growth Rate (2015-2020) (K Units)
Figure 40. Taiwan Obeticholic Acid Drug Sales Growth Rate (2015-2020) (K Units)
Figure 41. Indonesia Obeticholic Acid Drug Sales Growth Rate (2015-2020) (K Units)
Figure 42. Thailand Obeticholic Acid Drug Sales Growth Rate (2015-2020) (K Units)
Figure 43. Malaysia Obeticholic Acid Drug Sales Growth Rate (2015-2020) (K Units)
Figure 44. Philippines Obeticholic Acid Drug Sales Growth Rate (2015-2020) (K Units)
Figure 45. Vietnam Obeticholic Acid Drug Sales Growth Rate (2015-2020) (K Units)
Figure 46. Latin America Obeticholic Acid Drug Revenue Growth Rate 2015-2020 (Million US$)
Figure 47. Mexico Obeticholic Acid Drug Sales Growth Rate (2015-2020) (K Units)
Figure 48. Brazil Obeticholic Acid Drug Sales Growth Rate (2015-2020) (K Units)
Figure 49. Argentina Obeticholic Acid Drug Sales Growth Rate (2015-2020) (K Units)
Figure 50. Middle East and Africa Obeticholic Acid Drug Revenue Growth Rate 2015-2020 (Million US$)
Figure 51. Turkey Obeticholic Acid Drug Sales Growth Rate (2015-2020) (K Units)
Figure 52. Saudi Arabia Obeticholic Acid Drug Sales Growth Rate (2015-2020) (K Units)
Figure 53. U.A.E Obeticholic Acid Drug Sales Growth Rate (2015-2020) (K Units)
Figure 54. Intercept Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Dainippon Sumitomo Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Obeticholic Acid Drug Value Chain
Figure 57. Channels of Distribution
Figure 58. Distributors Profiles
Figure 59. North America Obeticholic Acid Drug Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 60. North America Obeticholic Acid Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 61. Europe Obeticholic Acid Drug Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 62. Europe Obeticholic Acid Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 63. Asia Pacific Obeticholic Acid Drug Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 64. Asia Pacific Obeticholic Acid Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 65. Latin America Obeticholic Acid Drug Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 66. Latin America Obeticholic Acid Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 67. Middle East and Africa Obeticholic Acid Drug Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 68. Middle East and Africa Obeticholic Acid Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed


【掲載企業】

Intercept Pharmaceuticals、Dainippon Sumitomo Pharma

★調査レポート[世界のオベチコール酸薬市場:成長動向・競争分析2020-2026] (コード:QYR20AP01627)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のオベチコール酸薬市場:成長動向・競争分析2020-2026]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆